Pharmacology: Drug Distribution in Body Fluids
38 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following is NOT a mechanism by which drugs can interact with transporters?

  • Facilitated diffusion
  • Carrier-mediated transport
  • Passive diffusion (correct)
  • Active transport
  • Pro-drugs are inactive precursors that are metabolized into active metabolites.

    True (A)

    What is the primary issue with delivering nucleic acid-based drugs?

    Their intracellular site of action

    The pro-drug valaciclovir has greater bioavailability than its active metabolite, ______.

    <p>acyclovir</p> Signup and view all the answers

    Match the following pro-drugs with their active metabolites:

    <p>Cyclophosphamide = Cyclophosphamide Levodopa = Dopamine Zidovudine = Zidovudine Valaciclovir = Acyclovir Diacetyl morphine = Morphine</p> Signup and view all the answers

    Which of the following is an example of a drug interaction affecting absorption?

    <p>Colestyramine binding drugs like warfarin and digoxin. (C)</p> Signup and view all the answers

    Drug interactions through alteration of distribution are always clinically significant.

    <p>False (B)</p> Signup and view all the answers

    What is the primary consequence of a drug displacing another drug from its binding site on plasma albumin?

    <p>Transient increase in free drug concentration followed by increased elimination.</p> Signup and view all the answers

    In jaundiced premature neonates, displacement of bilirubin from albumin can lead to ______, causing permanent movement disturbances.

    <p>kernicterus</p> Signup and view all the answers

    What are the four main bodily fluid compartments where drugs are distributed?

    <p>Intracellular, Extracellular, Transcellular, Intravascular (A)</p> Signup and view all the answers

    Match the following drugs with their mechanism of drug interaction:

    <p>Sulphonamides = Displacement of drugs from binding sites on plasma albumin Colestyramine = Binding to drugs in the gut, preventing their absorption Adrenaline = Vasoconstriction, slowing anaesthetic absorption Digoxin = Competition for transporters in the intestine and hepatocytes.</p> Signup and view all the answers

    The blood-brain barrier (BBB) is completely impermeable to all drugs.

    <p>False (B)</p> Signup and view all the answers

    Which of the following is NOT a potential consequence of drug displacement from binding sites on plasma albumin?

    <p>Increased elimination of the displaced drug. (D)</p> Signup and view all the answers

    Phenytoin dose adjustments based on total plasma concentration are always accurate, even in the presence of displacing drug interactions.

    <p>False (B)</p> Signup and view all the answers

    What are the two main forms in which a drug exists within bodily fluid compartments?

    <p>Free and bound</p> Signup and view all the answers

    Give an example of a drug that can displace digoxin from its binding sites.

    <p>Quinidine, verapamil, or amiodarone</p> Signup and view all the answers

    The ______ refers to the volume that would contain the total body content of a drug at the same concentration as in the plasma.

    <p>apparent volume of distribution (Vd)</p> Signup and view all the answers

    Match the following drug characteristics with their corresponding effect on drug distribution:

    <p>High lipid solubility = Enhanced penetration across cell membranes Large molecular size = Limited distribution, often confined to plasma Strong binding to plasma proteins = Reduced free drug concentration in the interstitial fluid Inflammation = Increased permeability of the blood-brain barrier</p> Signup and view all the answers

    Which of the following drugs is an example of a peripherally acting opioid antagonist with limited GI absorption and no CNS penetration?

    <p>Methylnaltrexone bromide (D)</p> Signup and view all the answers

    The volume of distribution (Vd) of a drug always reflects the actual volume of the compartment into which the drug is distributed.

    <p>False (B)</p> Signup and view all the answers

    Give one example of a drug that is confined to the plasma compartment due to its large molecular size.

    <p>Heparin</p> Signup and view all the answers

    Repeated dosing of a drug that is highly bound to plasma proteins can lead to an increase in the measured ______

    <p>Vd (volume of distribution)</p> Signup and view all the answers

    The blood-brain barrier completely prevents all drugs from reaching the central nervous system (CNS).

    <p>False (B)</p> Signup and view all the answers

    Which of the following drugs is classified as a Class 1 drug, where the dose is less than the binding capacity of plasma albumin?

    <p>Phenytoin (D)</p> Signup and view all the answers

    Drugs with a high volume of distribution (Vd) tend to be confined to the extracellular compartment.

    <p>False (B)</p> Signup and view all the answers

    What is the approximate total extracellular volume in liters per kilogram of body weight?

    <p>0.2 L/Kg</p> Signup and view all the answers

    Match the following drug classes/characteristics with their corresponding Vd:

    <p>Class 1 drugs (low dose/capacity ratio) = Extracellular volume Polar compounds = Extracellular volume Drugs readily crossing cell membranes = Total body water volume Drugs exceeding total body volume = Greater than total body water volume</p> Signup and view all the answers

    Which of the following factors can increase the volume of distribution of a drug?

    <p>Drug binding outside the plasma compartment (A), Partitioning into body fat (D)</p> Signup and view all the answers

    Drugs with a Vd greater than the total body water volume are effectively removed by hemodialysis.

    <p>False (B)</p> Signup and view all the answers

    What is the main mechanism by which gastrointestinal absorption can be slowed?

    <p>Drugs inhibiting gastric emptying</p> Signup and view all the answers

    Which of the following is NOT a currently licensed antibody drug conjugate by the FDA?

    <p>Bevacizumab (B)</p> Signup and view all the answers

    Liposomes are microscopic vesicles that can be used to deliver non-lipid soluble drugs.

    <p>True (A)</p> Signup and view all the answers

    What is the primary purpose of using a pro-drug strategy in drug development?

    <p>To enhance drug tolerability or increase drug efficacy by modifying the original drug molecule.</p> Signup and view all the answers

    The drug ______ is a potent immunosuppressant used to coat stents and prevent restenosis.

    <p>sirolimus</p> Signup and view all the answers

    Match the following drug delivery methods with their corresponding examples:

    <p>Antibody drug conjugates = Ado-trastuzumab emtansine Liposomes = Amphotericin B Coated implantable devices = Sirolimus-coated stents</p> Signup and view all the answers

    What is the primary mechanism by which antibody drug conjugates improve selectivity in cancer chemotherapy?

    <p>Targeting a specific tumor-associated antigen (A)</p> Signup and view all the answers

    Liposomal formulations of drugs have been shown to be more nephrotoxic (toxic to the kidneys) than traditional drug formulations.

    <p>False (B)</p> Signup and view all the answers

    What is the name of the type of drug delivery system that involves encapsulating a drug within a microscopic vesicle?

    <p>Liposomes</p> Signup and view all the answers

    Study Notes

    Drug Distribution in Bodily Fluid Compartments

    • Body water comprises 50-70% of body weight, varying between genders
    • Extracellular fluid (ECF) includes blood plasma (4.5%), interstitial fluid (16%), and lymph (1.2%)
    • Intracellular fluid (ICF) constitutes 30-40% body water
    • Transcellular fluid (2.5%) encompasses various specialized compartments (e.g., cerebrospinal, intraocular, peritoneal, pleural, synovial, digestive secretions)
    • Drugs exist in both free and bound forms within compartments
    • Drug distribution in aqueous compartments is influenced by fluid pH and drug pK.
    • Interstitial fluid accounts for ~16% of total body water
    • Intracellular fluid accounts for ~35% of total body water
    • Plasma water accounts for ~5% of total body water
    • Transcellular water accounts for ~2% of total body water
    • Fat tissues compose ~20% of total body water
    • Bound drug molecules are associated with proteins or other components
    • Free drug molecules are unbound and can move through different compartments
    • Drug distribution is influenced by the presence of specific transport mechanisms

    The Blood-Brain Barrier (BBB)

    • Introduced by Paul Ehrlich to explain a dye's inability to stain the brain after injection
    • Composed of continuous endothelial cells with tight junctions encircled by pericytes
    • Efflux pumps actively transport molecules, including drugs, out of the CNS, limiting access to the central nervous system.
    • Drugs with low lipid solubility typically struggle to penetrate the BBB
    • Efforts to improve CNS drug delivery often focus on altering permeability proteins
    • Inflammation can compromise BBB integrity and efflux pump activity
    • Specific drugs (e.g., penicillin) might be preferred for intravenous administration over intrathecal use in cases with significant inflammation

    Volume of Distribution

    • Defined as the volume that would contain the total body content of a drug at the same concentration as in plasma
    • Mathematically represented as Vd = Q/Cp (where Q = total body content of the drug, Cp = drug concentration in plasma)
    • It's important to avoid directly equating Vd with a specific body compartment.
    • Some drugs act at low concentrations, affecting receptors in various tissues (e.g., insulin acting on muscle, fat, and liver via interstitial fluid access, not just blood plasma)

    Drugs Confined to the Plasma Compartment

    • Plasma volume is approximately 0.05 L/kg of body weight
    • Certain drugs, like heparin, remain primarily confined to the plasma due to their large size or strong binding to plasma proteins
    • Pharmacological effects can arise even in cases of plasma binding; free drug in interstitial fluid can still exert therapeutic effects
    • Repeated dosing can result in equilibrium, leading to higher measured volume of distribution.
    • Certain dyes, like Evan's blue, bind strongly to plasma albumin, allowing for measurement of plasma volume
    • Class 1 drugs: Drug dose is less than the binding capacity of plasma albumin, resulting in lower dose/capacity ratio with most drug bound and less free drug
    • Class 2 drugs: Drug dose is more than the binding capacity of plasma albumin, resulting in higher dose/capacity ratio with a significant amount of free drug

    Drugs Confined in the Extracellular Compartment

    • Extracellular volume is roughly 0.2 L/kg body weight
    • Polar compounds (e.g., vecuronium, gentamicin, carbenicillin) typically have volumes of distribution closely resembling that of extracellular volume due to limited lipid solubility, thus their limited ability to cross cell membranes.
    • Macromolecular biopharmaceuticals, such as monoclonal antibodies, distribute in extracellular space but generally do not readily penetrate into cells.
    • Nucleic acid-based biologics are often intracellular, requiring specialized delivery.

    Drugs Confined to the Total Body Compartment

    • Total body volume roughly equals 0.55 L/kg
    • Drugs readily crossing cellular membranes (e.g., phenytoin, ethanol) frequently have volumes of distribution that are close to the total body water volume
    • Factors like drug binding outside plasma and partitioning into body fat can increase Vd
    • Certain drugs, including morphine, tricyclic antidepressants (TCAs), and haloperidol exceed total body volume
    • Haemodialysis may prove ineffective at removing drugs exceeding total body volume, as it mostly filters blood plasma

    Drug Interactions Caused by Altered Absorption

    • Gastrointestinal absorption can be modulated by drugs that influence gastric emptying (e.g., atropine, metoclopramide)
    • Drug interactions that affect absorption frequently involve changes in drug solubility or formation of drug complexes with dietary components (e.g., tetracycline’s reduced absorption in the presence of calcium or iron)
    • Physiological factors affecting absorption include vasoconstriction (e.g., adrenaline added to local anaesthetics), which can delay absorption
    • Pharmacodynamic modelling aids in predicting how genetic polymorphisms in drug transporters and their associated interactions with other drugs affect absorption

    Drug Interactions Through Alteration of Distribution

    • Drugs may compete for binding sites on plasma proteins or tissue proteins, leading to displacement
    • Displacement of a drug can temporarily raise free drug concentration before elimination, resulting in a new steady state with similar free drug concentrations but a different overall total drug concentration
    • Drug interactions involving alterations in distribution can have clinical significance
    • Dose adjustments may be necessary for co-administered drugs, particularly when considering their impact on free drug concentrations and elimination.

    Altered Distribution Because of Competition for Shared Transporters

    • Drug competition involving shared drug transporters (e.g., SLC and ABC transporters) can alter drug distribution, affecting absorption, excretion, and metabolism.
    • Drugs can compete for transport mechanisms, leading to altered pharmacokinetics
    • Examples include Organic Anion Transporters (OATs) affecting drug distribution to the CNS (e.g., penicillin).
    • New approaches to predict transporter interactions frequently utilize endogenous substrates as biomarkers for transporter function to improve the understanding and prediction accuracy of drug interactions involving transporter mechanisms

    Special Drug Delivery Systems

    • Pro-drugs, antibody-drug conjugates, and packaging in liposomes are examples of strategies to improve the delivery and efficacy of medications.
    • Coated implantable devices provide a controlled release of drugs.

    Pro-drugs

    • Inactive precursors are metabolised into active forms within the body
    • Examples of pro-drugs include cyclophosphamide, zidovudine, levodopa, and valaciclovir, and others
    • Pro-drug delivery systems may provide advantages, like enhanced tolerability, targeted delivery, or reduced side effects.

    Antibody-Drug Conjugates

    • Combines a monoclonal antibody with a cytotoxic drug to target specific cancer cells
    • Examples include ado-trastuzumab emtansine, brentuximab vedotin, and others.
    • Improving selectivity of cytotoxic agents against cancer cells.

    Packaging in Liposomes

    • Drug encapsulation within liposomes (e.g., amphotericin B, doxorubicin) can enhance drug delivery.
    • Modified liposomes can enhance delivery in certain applications

    Coated Implantable Devices

    • Used for drugs that may be delivered locally
    • Coated stents deliver agents to prevent re-stenosis or in other applications
    • Examples of implantable devices include intrauterine devices and stents.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    Explore the essential concepts of drug distribution within various bodily fluid compartments. This quiz covers the proportions of body water, extracellular and intracellular fluids, and the factors influencing drug distribution. Test your understanding of how drugs exist in free and bound forms in relation to fluid pH and drug pK.

    More Like This

    Pharmacology: Drug Distribution Process
    32 questions
    Pharmacology Chapter on Drug Distribution
    10 questions
    Pharmacology Drug Distribution
    48 questions
    Use Quizgecko on...
    Browser
    Browser